FDANews

LLY$1041.29▲ 0.28%
NVO$60.68▼ 2.65%
JNJ$218.21▼ 0.21%
MRK$109.45▲ 0.57%
ABBV$214.04▼ 0.14%
PFE$25.52▼ 0.51%
AMGN$331.00▲ 0.18%
VRTX$442.08▲ 0.16%
GILD$124.14▼ 0.62%
REGN$733.78▲ 0.10%
LLY$1041.29▲ 0.28%
NVO$60.68▼ 2.65%
JNJ$218.21▼ 0.21%
MRK$109.45▲ 0.57%
ABBV$214.04▼ 0.14%
PFE$25.52▼ 0.51%
AMGN$331.00▲ 0.18%
VRTX$442.08▲ 0.16%
GILD$124.14▼ 0.62%
REGN$733.78▲ 0.10%

Real-time FDA regulatory updates for the bio-pharma sector.

Just Approved

BRIUMVI

Decision Date: Aug 18, 2025 NDA # BLA761238

Recent Regulatory Decisions

View All
LOSARTAN POTASSIUM Sep 26, 2014

LOSARTAN POTASSIUM

HIKMA

IMPLANON Jan 18, 2007

ETONOGESTREL

ORGANON

METHYLPHENIDATE HYDROCHLORIDE Jan 15, 2026

METHYLPHENIDATE HYDROCHLORIDE

MOUNTAIN

OSELTAMIVIR PHOSPHATE Jan 15, 2026

OSELTAMIVIR PHOSPHATE

AJANTA PHARMA LTD

OXALIPLATIN Jan 15, 2026

OXALIPLATIN

SHANDONG

Upcoming Milestones

Full Calendar
31 JAN

PDUFA: Anaphylm (Aquestive)

Decision on sublingual film for Anaphylaxis.

08 FEB

PDUFA: RGX-121 (Regenxbio)

Priority review for MPS II treatment.

© 2026 FDA News. All rights reserved.